| NCT Number | NCT07486752 |
| Lead Sponsor | Rocket Pharmaceuticals Inc. |
| Conditions | Dilated Cardiomyopathy (DCM), Cardiovascular Diseases, Heart Diseases, Genetic Diseases |
| Enrollment | 30 participants |
| Start Date | 2026-05 |
| Primary Completion | 2032-12 (estimated) |
| Study Completion | 2033-03 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-20 |